Patents by Inventor Mami TSUCHIYA

Mami TSUCHIYA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240135246
    Abstract: A data generation method for generating data for domain generalization in machine learning includes performing, with a computer, augmentation using training data as raw data usable to train a machine learning model, and extracting, with the computer, a dataset including the raw data and data generated through the augmentation as a dataset for the domain generalization.
    Type: Application
    Filed: January 18, 2022
    Publication date: April 25, 2024
    Inventors: Mami Miyamoto, Seitaro Mura, Yuki Hirohashi, Atsushi Hashimoto, Takahiro Toku, Naoki Tsuchiya, Yoshihisa Ijiri, Yamato Okamoto
  • Patent number: 10494437
    Abstract: According to the present invention, a heterodimer protein composition that is composed of a first polypeptide comprising an immunoglobulin heavy chain constant region and a second polypeptide comprising CL-Fc prepared by fusion of an immunoglobulin light chain constant region (CL) and Fc region, and also has a deletion or substitution of Cys residues involved in disulfide bonds between CL and CH1, a purification method of the protein composition thereof, a preparation method of the protein composition thereof, a DNA and a vector encoding the protein composition thereof are provided.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: December 3, 2019
    Assignee: KYOWA KIRIN CO., LTD
    Inventors: Rinpei Niwa, Mami Tsuchiya, Takuya Murakami, Yuta Tezuka
  • Patent number: 10040861
    Abstract: Among N-glycoside-linked sugar chains which are bound to the Fc region of an antibody, sugar chains which are bound to Asn at position 297 relates to the activity and stability of the antibody in blood, but there is a possibility that extra sugar chains bound to the amino acid residues at positions other than 297 have influences upon the antibody constant region-mediated activity and a possibility of causing a problem of uniformity as a therapeutic antibody preparation. Accordingly, among N-glycoside-linked sugar chains which bind to the Fc region of the antibody, a method for controlling extra sugar chains which are bound to Asn residues at positions other than position 297 according to the EU index is required.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: August 7, 2018
    Assignee: KYOWA HAKKO KIRIN CO., LTD.
    Inventors: Rinpei Niwa, Mami Tsuchiya
  • Publication number: 20170362323
    Abstract: According to the present invention, a heterodimer protein composition that is composed of a first polypeptide comprising an immunoglobulin heavy chain constant region and a second polypeptide comprising CL-Fc prepared by fusion of an immunoglobulin light chain constant region (CL) and Fc region, and also has a deletion or substitution of Cys residues involved in disulfide bonds between CL and CH1, a purification method of the protein composition thereof, a preparation method of the protein composition thereof, a DNA and a vector encoding the protein composition thereof are provided
    Type: Application
    Filed: June 15, 2017
    Publication date: December 21, 2017
    Applicant: KYOWA HAKKO KIRIN CO., LTD
    Inventors: Rinpei NIWA, Mami TSUCHIYA, Takuya MURAKAMI, Yuta TEZUKA
  • Patent number: 9714291
    Abstract: According to the present invention, a heterodimer protein composition that is composed of a first polypeptide comprising an immunoglobulin heavy chain constant region and a second polypeptide comprising CL-Fc prepared by fusion of an immunoglobulin light chain constant region (CL) and Fc region, and also has a deletion or substitution of Cys residues involved in disulfide bonds between CL and CH1, a purification method of the protein composition thereof, a preparation method of the protein composition thereof, a DNA and a vector encoding the protein composition thereof are provided.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: July 25, 2017
    Assignee: KYOWA HAKKO KIRIN CO., LTD
    Inventors: Rinpei Niwa, Mami Tsuchiya, Takuya Murakami, Yuta Tezuka
  • Publication number: 20170190781
    Abstract: According to the present invention, anti-death receptor 3 (DR3) antagonistic IgG antibodies and antibody fragments thereof, wherein the antibodies and the antibody fragments thereof display a decreased agonistic activity or no agonistic activity for DR3 through their binding, an antibody compositions and an antibody fragment compositions comprising them, a nucleotide sequence encoding the antibody or the antibody fragment, a vector comprising the nucleotide sequences, an amino acid sequences of the antibodies or the antibody fragments, a method of producing the antibodies or the antibody fragments thereof, and a method of decreasing the agonistic potency of an antibody against DR3 through its binding, are provided.
    Type: Application
    Filed: October 8, 2015
    Publication date: July 6, 2017
    Applicant: KYOWA HAKKO KIRIN CO., LTD
    Inventors: David MILLS, Kazuma TOMIZUKA, John LAUDENSLAGER, Rinpei NIWA, Mami TSUCHIYA
  • Publication number: 20170166650
    Abstract: Among N-glycoside-linked sugar chains which are bound to the Fc region of an antibody, sugar chains which are bound to Asn at position 297 relates to the activity and stability of the antibody in blood, but there is a possibility that extra sugar chains bound to the amino acid residues at positions other than 297 have influences upon the antibody constant region-mediated activity and a possibility of causing a problem of uniformity as a therapeutic antibody preparation. Accordingly, among N-glycoside-linked sugar chains which bind to the Fc region of the antibody, a method for controlling extra sugar chains which are bound to Asn residues at positions other than position 297 according to the EU index is required.
    Type: Application
    Filed: December 16, 2016
    Publication date: June 15, 2017
    Applicant: KYOWA HAKKO KIRIN CO., LTD.
    Inventors: Rinpei NIWA, Mami TSUCHIYA
  • Patent number: 9556279
    Abstract: Among N-glycoside-linked sugar chains which are bound to the Fc region of an antibody, sugar chains which are bound to Asn at position 297 relates to the activity and stability of the antibody in blood, but there is a possibility that extra sugar chains bound to the amino acid residues at positions other than 297 have influences upon the antibody constant region-mediated activity and a possibility of causing a problem of uniformity as a therapeutic antibody preparation. Accordingly, among N-glycoside-linked sugar chains which bind to the Fc region of the antibody, a method for controlling extra sugar chains which are bound to Asn residues at positions other than position 297 according to the EU index is required.
    Type: Grant
    Filed: March 2, 2011
    Date of Patent: January 31, 2017
    Assignee: KYOWA HAKKO KIRIN CO., LTD.
    Inventors: Rinpei Niwa, Mami Tsuchiya
  • Publication number: 20140120581
    Abstract: According to the present invention, a heterodimer protein composition that is composed of a first polypeptide comprising an immunoglobulin heavy chain constant region and a second polypeptide comprising CL-Fc prepared by fusion of an immunoglobulin light chain constant region (CL) and Fc region, and also has a deletion or substitution of Cys residues involved in disulfide bonds between CL and CH1, a purification method of the protein composition thereof, a preparation method of the protein composition thereof, a DNA and a vector encoding the protein composition thereof are provided
    Type: Application
    Filed: October 4, 2013
    Publication date: May 1, 2014
    Applicant: KYOWA HAKKO KIRIN CO., LTD.
    Inventors: Rinpei NIWA, Mami TSUCHIYA, Takuya MURAKAMI, Yuta TEZUKA
  • Publication number: 20120010387
    Abstract: Among N-glycoside-linked sugar chains which are bound to the Fc region of an antibody, sugar chains which are bound to Asn at position 297 relates to the activity and stability of the antibody in blood, but there is a possibility that extra sugar chains bound to the amino acid residues at positions other than 297 have influences upon the antibody constant region-mediated activity and a possibility of causing a problem of uniformity as a therapeutic antibody preparation. Accordingly, among N-glycoside-linked sugar chains which bind to the Fc region of the antibody, a method for controlling extra sugar chains which are bound to Asn residues at positions other than position 297 according to the EU index is required.
    Type: Application
    Filed: March 2, 2011
    Publication date: January 12, 2012
    Applicant: KYOWA HAKKO KIRIN CO., LTD.
    Inventors: Rinpei NIWA, Mami TSUCHIYA